Angiotensin receptor blockers ameliorate collagen-induced arthritis in mice: comment on the article by Sagawa et al.
Hall
Frances C
FC
Dalbeth
Nicola
N
D047228:Angiotensin II Type 1 Receptor Blockers / Q000627:therapeutic use*; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000627:therapeutic use*; D000818:Animals; D001169:Arthritis, Experimental / Q000139:chemically induced / Q000188:drug therapy* / Q000503:physiopathology; D001562:Benzimidazoles / Q000627:therapeutic use; D001713:Biphenyl Compounds; D049109:Cell Proliferation / Q000187:drug effects; D024043:Collagen Type II / Q000494:pharmacology; D004195:Disease Models, Animal; D007093:Imidazoles / Q000627:therapeutic use; D007596:Joints / Q000187:drug effects / Q000473:pathology; D008297:Male; D051379:Mice; D008811:Mice, Inbred DBA; D000068557:Olmesartan Medoxomil; D010047:Ovalbumin / Q000494:pharmacology; D000077583:Quinapril; D013601:T-Lymphocytes / Q000187:drug effects / Q000276:immunology / Q000473:pathology; D044005:Tetrahydroisoquinolines / Q000627:therapeutic use*; D013777:Tetrazoles / Q000627:therapeutic use
D047228:Angiotensin II Type 1 Receptor Blockers; D000806:Angiotensin-Converting Enzyme Inhibitors; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D024043:Collagen Type II; D007093:Imidazoles; D044005:Tetrahydroisoquinolines; D013777:Tetrazoles; D000068557:Olmesartan Medoxomil; D010047:Ovalbumin; D000077583:Quinapril; C081643:candesartan